James A Johnson
CIK 1225501 · Chief Financial Officer · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ZGEN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL, WA 98011
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LONA | Director | — | $2.38 | — | $0 | 2 | 2026-06-24 |
| LeonaBio, Inc. (ATHA) Delisted | Director | 500 | $6.92 | $3.5K | $12.0K | 6 | 2025-06-03 |
| NanoString Technologies Inc (NSTG) Delisted | Chief Financial Officer | 8,548 | $0.11 | $900 | -$225.7K | 13 | 2017-09-05 |
| ZYMOGENETICS INC (ZGEN) Delisted | Executive VP and CFO | 0 | $12.01 | $0 | -$325.0K | 12 | 2010-10-12 |
Recent Filings · Page 2 of 4
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-02-08 | NanoString Technologies Inc (NSTG) Delisted | Mixed | +2,244 | -$20.5K | EDGAR |
| 2016-11-14 | NanoString Technologies Inc (NSTG) Delisted | Mixed | — | -$174.5K | EDGAR |
| 2016-09-06 | NanoString Technologies Inc (NSTG) Delisted | Grant (A) | +620 | $7.5K | EDGAR |
| 2016-03-03 | NanoString Technologies Inc (NSTG) Delisted | Grant (A) | +760 | $7.2K | EDGAR |
| 2016-02-05 | NanoString Technologies Inc (NSTG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-09-03 | NanoString Technologies Inc (NSTG) Delisted | Grant (A) | +761 | $7.2K | EDGAR |
| 2015-03-04 | NanoString Technologies Inc (NSTG) Delisted | Grant (A) | +789 | $7.5K | EDGAR |
| 2015-02-11 | NanoString Technologies Inc (NSTG) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-09-04 | NanoString Technologies Inc (NSTG) Delisted | Grant (A) | +1,063 | $7.0K | EDGAR |
| 2014-03-05 | NanoString Technologies Inc (NSTG) Delisted | Grant (A) | +1,096 | $7.3K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).